NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Mumps Vaccines



Reports from Norwegian Institute of Public Health, Division of Infectious Disease highlight recent research in mumps vaccines



July 30th, 2008

Researchers detail in 'Detection of measles- and mumps-specific IgG antibodies in paired serum and oral fluid samples from Norwegian conscripts,' new data in mumps. According to a study from Oslo, Norway, "The aim of this study was to measure the seroprevalence to mumps in Norwegian conscripts belonging to the first children vaccination cohorts that had been offered two doses of MMR vaccine. The seroprevalence to mumps was 76% with the Microimmune assay and 85% with the Enzygnost assay."

"We also compared the performance of the Microimmune assay for detection of mumps-and measles-specific IgG antibodies in 340 paired serum and oral fluid samples from the conscripts and...


Source: Vaccine Weekly (2008-07-30)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login